S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
NYSE:BSX

Boston Scientific Short Interest Ratio and Short Volume

$43.23
+0.19 (+0.44%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$42.86
$43.95
50-Day Range
$38.07
$44.86
52-Week Range
$35.04
$46.28
Volume
11.68 million shs
Average Volume
9.31 million shs
Market Capitalization
$61.60 billion
P/E Ratio
59.22
Dividend Yield
N/A
Beta
0.89

Boston Scientific (NYSE:BSX) Short Interest Data

Current Short Volume
15,400,000 shares
Previous Short Volume
15,120,000 shares
Change Vs. Previous Month
+1.85%
Dollar Volume Sold Short
$690.84 million
Short Interest Ratio / Days to Cover
1.9
Last Record Date
January, 15 2022
Outstanding Shares
1,424,993,000 shares
Float Size
1,410,000,000 shares
Short Percent of Float
1.09%
Today's Trading Volume
11,681,952 shares
Average Trading Volume
9,306,576 shares
Today's Volume Vs. Average
25.52%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Boston Scientific ?

Sign up to receive the latest short interest report for Boston Scientific and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time


Boston Scientific (NYSE:BSX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/202215,400,000 shares $690.84 million +1.9%1.1%1.9 $44.86
12/31/202115,120,000 shares $642.30 million +11.5%1.1%2 $42.48
12/15/202113,560,000 shares $545.65 million -7.8%1.0%1.8 $40.24
11/30/202114,700,000 shares $559.63 million -6.4%1.0%2.1 $38.07
11/15/202115,710,000 shares $649.45 million -26.0%1.1%2.4 $41.34
10/29/202121,220,000 shares $915.22 million -6.0%1.5%3.3 $43.13
10/15/202122,570,000 shares $979.54 million -5.1%1.6%3.6 $43.40
9/30/202123,790,000 shares $1.03 billion +15.8%1.7%3.7 $43.39
9/15/202120,540,000 shares $924.51 million +2.7%1.5%3.2 $45.01
8/31/202120,000,000 shares $903 million +19.0%1.4%3.2 $45.15
8/13/202116,810,000 shares $745.19 million +17.9%1.2%2.6 $44.33
7/30/202114,260,000 shares $650.26 million +15.5%1.0%2.2 $45.60
7/15/202112,350,000 shares $520.68 million -2.8%N/A1.9 $42.16
6/30/202112,710,000 shares $543.48 million -5.2%N/A1.8 $42.76
6/15/202113,400,000 shares $572.85 million +17.5%N/A1.9 $42.75
5/28/202111,400,000 shares $485.07 million -2.9%N/A1.6 $42.55
5/14/202111,740,000 shares $488.50 million -29.4%N/A1.5 $41.61
4/30/202116,620,000 shares $732.94 million +13.8%N/A2 $44.10
4/15/202114,610,000 shares $579.58 million -3.2%N/A1.7 $39.67
3/31/202115,090,000 shares $587.91 million -15.1%N/A1.6 $38.96
3/15/202117,780,000 shares $690.75 million -0.2%N/A1.8 $38.85
2/26/202117,810,000 shares $706.52 million -2.3%N/A1.5 $39.67
2/12/202118,230,000 shares $708.60 million +26.8%N/A1.5 $38.87
1/29/202114,380,000 shares $522.57 million -6.6%N/A1.1 $36.34
1/15/202115,400,000 shares $556.86 million +2.2%N/A1.1 $36.16













Boston Scientific (NYSE:BSX) Short Interest Frequently Asked Questions

What is Boston Scientific's current short interest?

Short interest is the volume of Boston Scientific shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 15,400,000 shares of BSX short. 1.09% of Boston Scientific's shares are currently sold short. Learn More on Boston Scientific's current short interest.

What is a good short interest ratio for Boston Scientific?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Boston Scientific currently has a short interest ratio of 2.0. Learn More on a good short interest ratio for Boston Scientific

Which institutional investors are shorting Boston Scientific?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: CenterStar Asset Management LLC, Jefferies Group LLC, Mint Tower Capital Management B.V., BNP Paribas Arbitrage SA, Mint Tower Capital Management B.V., Jane Street Group LLC, Squarepoint Ops LLC, UBS Group AG, Laurion Capital Management LP, Millennium Management LLC, Citadel Advisors LLC, Point72 Hong Kong Ltd, Tudor Investment Corp Et Al, Capstone Investment Advisors LLC, Caas Capital Management LP, PEAK6 Investments LLC, Cowen AND Company LLC, Wolverine Trading LLC, Goldman Sachs Group Inc., HAP Trading LLC, Allianz Asset Management GmbH, Citigroup Inc., Barclays PLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Boston Scientific?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.09% of Boston Scientific's floating shares are currently sold short.

Is Boston Scientific's short interest increasing or decreasing?

Boston Scientific saw a increase in short interest in January. As of January 15th, there was short interest totaling 15,400,000 shares, an increase of 1.9% from the previous total of 15,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Boston Scientific's float size?

Boston Scientific currently has issued a total of 1,424,993,000 shares. Some of Boston Scientific's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Boston Scientific currently has a public float of 1,410,000,000 shares.

How does Boston Scientific's short interest compare to its competitors?

1.09% of Boston Scientific's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "health care equipment" compare to Boston Scientific: Abbott Laboratories (0.51%), Medtronic plc (0.89%), Intuitive Surgical, Inc. (0.00%), Stryker Co. (1.45%), Becton, Dickinson and Company (1.26%), Edwards Lifesciences Co. (0.88%), Baxter International Inc. (0.93%), IDEXX Laboratories, Inc. (0.00%), DexCom, Inc. (0.00%), and ResMed Inc. (0.55%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.74 billion), S&P Global Inc. ($7.90 billion), Charter Communications, Inc. ($5.88 billion), Lucid Group Inc ($3.75 billion), Palo Alto Networks, Inc. ($3.44 billion), Wayfair Inc. ($2.88 billion), Rivian ($2.60 billion), Zscaler, Inc. ($1.86 billion), ViacomCBS Inc. ($1.82 billion), and Match Group, Inc. ($1.79 billion). View all of the most shorted stocks.

What does it mean to sell short Boston Scientific stock?

Short selling BSX is an investing strategy that aims to generate trading profit from Boston Scientific as its price is falling. Boston Scientific's stock is trading up $0.19 today. To short Boston Scientific stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Boston Scientific will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Boston Scientific?

A short squeeze for Boston Scientific occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BSX, which in turn drives the price of the stock up even further.

How often is Boston Scientific's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSX, twice per month. The most recent reporting period available is January, 15 2022.



This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.